Lapatinib Resistance in Patients With Breast Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the
laboratory may help doctors learn more about cancer and the development of drug resistance in
patients.
PURPOSE: This research study is looking at lapatinib resistance in patients with breast
cancer.